North America Analysis
Home Search

immunology - search results

If you're not happy with the results, please do another search
Benyamin Rosental

Benyamin Rosental – Ben Gurion University of the Negev

PROFESSIONAL PREPARATION: Ben-Gurion University, Israel, Life Sciences. B.Sc., 2007 Ben-Gurion University, Israel, Microbiology and Immunology. M.Med.Sc., 2010 Ben-Gurion University, Israel, Immunology. Ph.D., 2013 Stanford University, CA, USA, Stem Cells and Comparative Immunology.Postdoc., 2018 Head of Comparative Immunology and Stem Cells Transplantation Laboratory Our laboratory research is focusing on tissue acceptance by the immune system, and stem cell...
viral evolution animals

The viral evolution of COVID-19 in animals

New research analyses mutation types occurring in the Coronavirus after infection in cats, dogs, ferrets, and hamsters, studying cross-species transmission in animals.
next-generation sequencing

How can next-generation sequencing create treatments for diseases?

In this ebook, we interview Dr Richie Kohman, Synthetic Biology Platform Lead at the Wyss Institute at Harvard, about his work with next-generation sequencing (NGS).
food allergies

Food allergies: An epidemic in the making?

Aarthi JanakiRaman, Research Director, Chemicals and Advanced Materials at TechVision, sheds light on food allergies and considers if this is an epidemic
vaccines and immunotherapeutics, immunotherapeutics

Emphasising vaccines and immunotherapeutics research worldwide

Here, Open Access Government interview Dr Babita Agrawal, Professor in the Department of Surgery, University of Alberta to discuss the continued need for research into vaccines and immunotherapeutics.
COVID-19 antibody response

Third of leukaemia patients show no COVID-19 antibody response

According to a new study, a third of leukaemia patients fail to generate an antibody response following two COVID-19 vaccine doses.
Glycoscience

Piecing Glycoscience together

Frederique Lisacek from SIB Swiss Institute of Bioinformatics, discusses the experimental approaches towards Glycoscience and emphasises the need for collecting and integrating glyco-related information.
brain immune response, viral encephalitis

Filling in the gaps of brain immune response

Open Access Government spoke to Dr Robyn S. Klein, MD, PhD, about her ground-breaking work in neuroimmunology and the path to understanding the links between viral encephalitis and memory disorders.
menstrual cycle COVID vaccine,menstruation covid

NIH funds menstrual cycle and COVID vaccine research

McLean Hospital’s Clinical and Translational Pain Research Laboratory is one of five institutions splitting a $1.67 million NIH grant - the research will examine any links between the menstrual cycle and the COVID vaccine.
therapies for cats

Neurological disorders: Developing therapies for cats, dogs & patients

Charles H. Vite, DVM, PhD from School of Veterinary Medicine at University of Pennsylvania, focuses on a fascinating aspect of neurological disorders concerning developing therapies for cats, dogs & patients.
Prof. Hartmut J. Ehrlich

Prof. Hartmut J. Ehrlich – Abivax SA

Prof. Hartmut J. Ehrlich, MD, has more than 35 years of experience in leading positions in the biopharmaceutical industry In his role as VP and Head of Global Research and Development at Baxter Biosciences, he has overseen the development and regulatory approval of key biologics in the specialty areas of...
glycoscience

Glycoscience offers opportunities galore in healthcare

Aarthi JanakiRaman, Research Director, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, explains how glycoscience offers opportunities galore in healthcare.
brain inflammation

Rare case of brain inflammation after mild COVID-19 infection

Physicians at University of California San Diego School of Medicine describe the first known case of a young, healthy adult who suffered brain inflammation after mild COVID-19 infection.
second dose

Study highlights importance of second COVID-19 vaccine

Findings from a new study strongly emphasise why the second dose of the COVID-19 vaccine should not be skipped.
HIV vaccine, clinical trial HIV

Oxford University launch clinical trial for HIV vaccine

The team will have results to discuss in April, 2022 - they nurse the hope that this HIV vaccine could stop different geographical strains, after 40 years of no cure.
inclusivity in science

Science should be for everyone

Open Access Government take a look at the British Science Association’s work to foster inclusivity in science, creating community cohesion and engagement.
increase antimicrobial resistance, microbiome

Study says international travel increases antimicrobial resistance

A new study confirms that antimicrobial resistance increases as people travel internationally, with one scientist commenting that the world faces "a worrisome problem on the horizon".
Food Allergy Research and Resource Program

AllergenOnline.org – founded by Dr. Richard E. Goodman

Dr. Richard E. Goodman created the allergen database, including a celiac database, for checking for similarities to allergens or celiac eliciting peptides.
GE crops

GE crops: Biotech and novel food safety conflicts

Dr Richard E. Goodman of the Food Allergy Research and Resource Program discusses GE crops and the US FDA, EFSA and CODEX international guidelines
antibodies 11 months, COVID

COVID patients have antibodies “11 months after first symptoms”

Scientists are explaining that antibody production doesn't stop, it simply plateaus - in some people, COVID antibodies exist "11 months after first symptoms".

Follow Open Access Government